Jung Eun Park

Jung Eun Park

Auto-generated profile, based on publicly available information

Jung Eun Park

College of Korean Medicine, Gachon University, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2026 in Drug Targets and Therapeutics
Verified
Journal Article
Open access
PDF file
CCChan Hee Cho
Chan Hee Cho
JPJung Eun Park
Jung Eun Park
JJJong-Sik Jin
Jong-Sik Jin
CLChangjin Lim
Changjin Lim
HSHyun Joo Shim
Hyun Joo Shim
Ki Hyun KimKi Hyun Kim
Ki Hyun Kim
Chan Hee Cho, Jung Eun Park, Jong-Sik Jin, Changjin Lim, Hyun Joo Shim, Ki Sung Kang, Ki Hyun Kim. DTT 2026;5:99-108. https://doi.org/10.58502/DTT.26.0016

30 June 2026 in Perspectives on Integrative Medicine
Verified
Journal Article
Open access
JPJung Eun Park
Jung Eun Park
JJJisol Jang
Jisol Jang
JKJaeHa Kang
JaeHa Kang
YCYounglong Choi
Younglong Choi
JLJi Hwan Lee
Ji Hwan Lee
Ki Sung  KangKi Sung Kang
Ki Sung Kang
Background: Type 2 diabetes mellitus involves multifactorial metabolic dysfunction necessitating therapeutic strategies capable of modulating multiple biological pathways.Methods: This study implemented a 4-stage integrated screening platform to identify natural products with multitarget antidiabetic potential.Results: Five plant samples samples were evaluated through α-glucosidase inhibition, protein tyrosine phosphatase 1B inhibition, glucoseuptake enhancement assays in C2C12 myotubes, and network pharmacology. Amongst them, Lagerstroemia speciosa (banaba leaf) was the only material that demonstrated coherent activity across all assays. Banaba extract significantly inhibited α-glucosidase, enhanced glucose uptake in a dose-dependent manner, and exhibited measurable protein tyrosine phosphatase suppression. Network pharmacology further supported these findings and 13 overlapping targets and 19 hub genes enriched in insulin signaling pathways (PI3K-Akt, AMPK, MAPK, and FOXO) were identified. This reflected strong mechanistic relevance of banaba leaf to Type 2 diabetes mellitus.Conclusion: Collectively, these results demonstrate the utility of a systematic, multilevel screening framework which highlights banaba leaf as a promising candidate for further antidiabetic research. Nevertheless, reliance on in vitro and in silico analyses underscores the need for in vivo validation to determine physiological efficacy, bioavailability, and systemic metabolic effects.